175 related articles for article (PubMed ID: 21224072)
1. Proteasome inhibitors induce p53-independent apoptosis in human cancer cells.
Pandit B; Gartel AL
Am J Pathol; 2011 Jan; 178(1):355-60. PubMed ID: 21224072
[TBL] [Abstract][Full Text] [Related]
2. A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line.
Yerlikaya A; Okur E; Baykal AT; Acılan C; Boyacı I; Ulukaya E
J Proteomics; 2015 Jan; 113():315-25. PubMed ID: 25305590
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibitor MG132 induces thyroid cancer cell apoptosis by modulating the activity of transcription factor FOXO3a.
Qiang W; Sui F; Ma J; Li X; Ren X; Shao Y; Liu J; Guan H; Shi B; Hou P
Endocrine; 2017 Apr; 56(1):98-108. PubMed ID: 28220348
[TBL] [Abstract][Full Text] [Related]
4. A coordinated action of Bax, PUMA, and p53 promotes MG132-induced mitochondria activation and apoptosis in colon cancer cells.
Ding WX; Ni HM; Chen X; Yu J; Zhang L; Yin XM
Mol Cancer Ther; 2007 Mar; 6(3):1062-9. PubMed ID: 17363499
[TBL] [Abstract][Full Text] [Related]
5. p53-Independent up-regulation of a TRAIL receptor DR5 by proteasome inhibitors: a mechanism for proteasome inhibitor-enhanced TRAIL-induced apoptosis.
Seol DW
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):222-5. PubMed ID: 22120628
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
Wagenknecht B; Hermisson M; Eitel K; Weller M
Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
Hougardy BM; Maduro JH; van der Zee AG; de Groot DJ; van den Heuvel FA; de Vries EG; de Jong S
Int J Cancer; 2006 Apr; 118(8):1892-900. PubMed ID: 16287099
[TBL] [Abstract][Full Text] [Related]
8. Differential apoptotic response to the proteasome inhibitor Bortezomib [VELCADE, PS-341] in Bax-deficient and p21-deficient colon cancer cells.
Yu J; Tiwari S; Steiner P; Zhang L
Cancer Biol Ther; 2003; 2(6):694-9. PubMed ID: 14688479
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proteasome function induced apoptosis in gastric cancer.
Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK
Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibition as a novel mechanism of the proapoptotic activity of γ-secretase inhibitor I in cutaneous T-cell lymphoma.
Biskup E; Kamstrup MR; Manfé V; Gniadecki R
Br J Dermatol; 2013 Mar; 168(3):504-12. PubMed ID: 23445313
[TBL] [Abstract][Full Text] [Related]
11. Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.
Hur J; Bell DW; Dean KL; Coser KR; Hilario PC; Okimoto RA; Tobey EM; Smith SL; Isselbacher KJ; Shioda T
Cancer Res; 2006 Oct; 66(20):10153-61. PubMed ID: 17047080
[TBL] [Abstract][Full Text] [Related]
12. Wild-type p53 protects normal cells against apoptosis induced by thiostrepton.
Halasi M; Schraufnagel DP; Gartel AL
Cell Cycle; 2009 Sep; 8(17):2850-1. PubMed ID: 19652535
[TBL] [Abstract][Full Text] [Related]
13. Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib.
Ooi MG; Hayden PJ; Kotoula V; McMillin DW; Charalambous E; Daskalaki E; Raje NS; Munshi NC; Chauhan D; Hideshima T; Buon L; Clynes M; O'Gorman P; Richardson PG; Mitsiades CS; Anderson KC; Mitsiades N
Clin Cancer Res; 2009 Dec; 15(23):7153-60. PubMed ID: 19934289
[TBL] [Abstract][Full Text] [Related]
14. New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer.
Pandit B; Gartel AL
Prostate; 2010 Jun; 70(8):825-33. PubMed ID: 20058240
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation.
Chen JJ; Chou CW; Chang YF; Chen CC
J Immunol; 2008 Jun; 180(12):8030-9. PubMed ID: 18523266
[TBL] [Abstract][Full Text] [Related]
16. FoxM1 is a general target for proteasome inhibitors.
Bhat UG; Halasi M; Gartel AL
PLoS One; 2009 Aug; 4(8):e6593. PubMed ID: 19672316
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitors induce apoptosis in human lung cancer cells through a positive feedback mechanism and the subsequent Mcl-1 protein cleavage.
Yuan BZ; Chapman J; Reynolds SH
Oncogene; 2009 Oct; 28(43):3775-86. PubMed ID: 19684616
[TBL] [Abstract][Full Text] [Related]
18. Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor.
Wu T; Chen W; Zhong Y; Hou X; Fang S; Liu CY; Wang G; Yu T; Huang YY; Ouyang X; Li HQ; Cui L; Yang Y
Mol Cancer Ther; 2017 Apr; 16(4):717-728. PubMed ID: 27903750
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of DNA damage-induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3sigma and survivin.
Vaziri SA; Hill J; Chikamori K; Grabowski DR; Takigawa N; Chawla-Sarkar M; Rybicki LR; Gudkov AV; Mekhail T; Bukowski RM; Ganapathi MK; Ganapathi R
Mol Cancer Ther; 2005 Dec; 4(12):1880-90. PubMed ID: 16373703
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells.
Kitagawa H; Tani E; Ikemoto H; Ozaki I; Nakano A; Omura S
FEBS Lett; 1999 Jan; 443(2):181-6. PubMed ID: 9989601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
